Project Grant G2640091

The Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) awarded a $2,248,167 Project Grant under the Rural Health Research Centers program (CFDA 93.155) to the Wilson County Substance Abuse Coalition in Wilson, North Carolina. The grant, awarded on September 1, 2024, supports the "Rural Communities Opioid Response Program-Impact" initiative, which focuses on addressing substance abuse and mental health challenges in rural Wilson County...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,499,606 to Dartmouth-Hitchcock Clinic to conduct a population-level analysis of 1.7 million maternal-infant dyads insured by Medicaid. The primary objectives are to: 1) characterize disparities in the diagnosis of neonatal opioid withdrawal syndrome (NOWS) across 150 hospitals; 2) determine the cumulative incidence of...

The U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) awarded a $1,500,000 Project Grant under the Rural Health Research Centers program (CFDA 93.155) to Casa-Trinity Inc., a non-profit organization located in Geneseo, New York. The grant, titled "RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT", aims to address the opioid epidemic in six western New York counties by expanding access to medication-assisted treatment, recovery services,...

This $2,250,000 Rural Communities Opioid Response Program-Impact grant, awarded by the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) under the Rural Health Research Centers program (CFDA 93.155), will support a comprehensive effort to transform the response to substance use disorder (SUD) in rural Colorado. The key products and services to be delivered include: Establishing a new methadone clinic to improve access to medication for opioid use...

This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...

The U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) awarded a $3,000,000 Project Grant under the Rural Health Research Centers program (CFDA 93.155) to the Ohiohealth Research Institute in Columbus, Ohio. The grant titled "RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT - THE CONNECTIONS TO TREATMENT AND RECOVERY PROJECT" aims to improve access to comprehensive, evidence-based substance use disorder (SUD) and opioid use disorder...

The Nevada State Opioid Response (SOR) Program, funded by a $83,174,470 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, aims to combat the opioid and stimulant crisis in Nevada. Key products and services delivered through this funding include: Expanding access to evidence-based opioid and stimulant use disorder...

This federal Project Grant award of $3,750,000 was provided by the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) under the Rural Health Research Centers program (CFDA 93.155). The grant will support the "RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT" project, which aims to establish the ATLAS Center to enhance substance use disorder (SUD) treatment and recovery services, develop a responsive workforce, improve coordination...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a research project entitled "Optimizing Developmental Outcomes in Early Childhood After Neonatal Opioid Withdrawal Syndrome." The $180,059 award, effective August 1, 2024, will fund a 5-year longitudinal study to assess the independent and moderating effects of positive childhood experiences (PCEs) and adverse childhood experiences...

The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...